Surjan, Juliana
Grossi, Julia Diniz
Del Porto, José Alberto
Delfino, Rodrigo Simonini
de Oliveira Cerqueira, Raphael
Lucchese, Ana Cecília
Magalhães, Eduardo
Del Sant, Lorena Catarina
Tuena, Marco Aurélio
Nakahira, Carolina
Fava, Victor Augusto Rodovalho
Steglich, Matheus Souza
Abdo, Guilherme Lozi
Barbosa, Matheus Ghossain
Sarin, Luciana Maria
Lacerda, Acioly Luiz Tavares
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Article History
Accepted: 11 August 2022
First Online: 31 August 2022
Declarations
:
: This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). The funding institutions played no role in the study design, data collection, statistical analysis, or data interpretation, in the manuscript writing, or in the decision to submit the article for publication.
: Acioly Luiz Tavares Lacerda has received consulting fees from Hoffmann-La Roche, Genentech, Janssen Pharmaceutical, Daiichi Sankyo, Cristalia Produtos Químicos e Farmacêuticos, Pfizer, Mantecorp Indústria Química e Farmacêutica, Libbs Farmacêutica, FQM Farma, and Sanofi-Aventis over the last 24 months and has received research fees from Janssen Pharmaceutical, Eli Lilly, H. Lundbeck A/S, Servier Laboratories, Hoffman-La Roche, FQM Farma, and Forum Pharmaceuticals. Juliana Surjan reports personal fees from Cristalia Produtos Químicos e Farmacêuticos and Abbot and non-financial support from Janssen Pharmaceutical, outside the submitted work. Carolina Nakahira reports non-financial support from Eurofarma, Sanofi-Aventis, and Cristalia Produtos Quimicos e Farmaceuticos, outside the submitted work. Raphael de Oliveira Cerqueira reports personal fees from Janssen Pharmaceutical and Abbot, outside the submitted work. Luciana Maria Sarin reports personal fees from Daiichi Sankyo Brasil, Lundbeck A/S, Pfizer, and Janssen Pharmaceutical, and non-financial support from Takeda Brasil, Moksha8 Brasil, and Torrent Pharma, outside the submitted work. Eduardo Magalhães reports non-financial support from Torrent Pharma and Hypera Pharma, outside the submitted work. José Alberto Del Porto reports being an active speaker and board advisor at Daiichi Sankyo Brasil, Pfizer, Janssen Pharmaceutical, Cristalia Produtos Quimicos e Farmaceuticos, Libbs Farmaceutica, H. Lundbeck A/S, Wyeth, Ache Laboratorios Farmaceuticos, and Eurofarma. The remaining authors declare no potential conflicts of interest.
: The study was approved by the local institutional review board (no. 3.115.329). All procedures in this study were in accordance with the 1964 Declaration of Helsinki.
: All participants signed the approved version of the written informed consent before performing any procedure related to the study. Patients were asked to attend all treatment sessions accompanied by a responsible adult. All interviews were conducted by trained psychiatrists. Data were inserted into a databank using the RedCap platform.
: Not applicable.
: The datasets analyzed in the current study are not publicly available because of local policies.
: Not applicable.
: ALTL designed the study, wrote the protocol, undertook statistical analyses, and revised the manuscript. JS wrote the manuscript, participated in the data collection, and interpreted the results. JDG helped write the manuscript and analyze the results. JADP helped design the study and implement the study’s research unit. LMS helped design the study, write the protocol, and implement the study’s research unit. RSD participated in the data collection and helped extract data from the bank. ROC helped write the manuscript. EM, LCDS, ACL, MAT, CN, VARF, MSS, and MGB participated in the data collection.